Information Provided By:
Fly News Breaks for February 5, 2020
EOLS
Feb 5, 2020 | 17:12 EDT
Mizuho analyst Vamil Divan assumed coverage of Evolus with a Buy rating and $20 price target. The analyst notes that he is "encouraged" by the uptake of its lead asset Jeuveau and sees "significant" upside potential for its sales. Divan adds that he expects Evolus to either prevail or settle with a "reasonable royalty" payment in its ongoing related litigation.
News For EOLS From the Last 2 Days
EOLS
Apr 22, 2021 | 08:54 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - Renalytix... To see the rest of the story go to thefly.com. See Story Here
EOLS
Apr 21, 2021 | 18:51 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGSQualtrics... To see the rest of the story go to thefly.com. See Story Here
EOLS
Apr 21, 2021 | 16:02 EDT
SVB Leerink, Stifel and Cantor are acting as joint bookrunning managers for the offering.